| [1] |
Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma[J]. Cancer, 1982, 50(5): 970-981.
|
| [2] |
Insabato L, Di Vizio D, Terracciano LM, et al. Epithelioid haemangioendothelioma of the breast[J]. Breast, 1999, 8(5): 295-297.
|
| [3] |
徐静，刘新梅，王绪麟，等．乳腺上皮样血管内皮瘤一例[J/CD]．中华临床医师杂志(电子版), 2013, 7(21): 162-163.
|
| [4] |
Blay JY, Piperno-Neumann S, Watson S, et al. Epithelioid hemangio-endothelioma(EHE) in NETSARC: the nationwide series of 267 patients over 12 years[J]. Eur J Cancer, 2023，192：113 262.
|
| [5] |
Jung R, Janardhan HP, Dresser K, et al. Sustained activation of endothelial YAP1 causes epithelioid hemangioendothelioma[J]. Arterioscler Thromb Vasc Biol, 2021, 41(7): 2233-2235.
|
| [6] |
Hahn E, Dickson BC, Gupta AA, et al. Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer[J]. Genes Chromosomes Cancer, 2021, 60(2): 112-115.
|
| [7] |
Somers N, Creytens D, Van Belle S, et al. Diagnosis of epithelioid hemangioendothelioma eight days postpartum: is there a link with pregnancy? A case report and review of the literature[J]. Acta Clinica Belgica, 2022, 77(1): 157-162.
|
| [8] |
Ren L, Fei X, Zhu Y, et al. Ultrasound and contrast-enhanced ultrasound imaging in hepatic epithelioid hemangioendothelioma: a retrospective study of 13 patients[J]. Med Ultrason，2022，24(4)：414-420.
|
| [9] |
Zhao HG, Zhang KW, Hou S, et al. Femoral epithelioid hemangioendothelioma detected with magnetic resonance imaging and positron emission tomography/computed tomography: a case report[J]．World J Clin Cases, 2021, 9(6): 1353.
|
| [10] |
Wei W, Huang G, Liu J. Advancing the diagnosis of epithelioid hemangioendothelioma by 18F-FDG PET/CT[J]．Am J Nucl Med Mol Imaging, 2021, 11(3): 230.
|
| [11] |
李卓，杜强，马沛卿，等．肝上皮样血管内皮瘤14例临床病理学特点分析[J]．中华病理学杂志，2021，50(5)：511-513.
|
| [12] |
Mundada AD, Deodhar K, Ramadwar M, et al. Hepatic epithelioid hemangioendothelioma: a clinocopathological correlation[J]．Indian J Pathol Microbiol, 2022, 65(1): 133-136.
|
| [13] |
Witte S, Weidema M, Kaal S, et al. The heterogeneity of epithelioid hemangioendothelioma (EHE): a case series and review of the literature with emphasis on treatment options[J]. Semin Oncol，2021，48(2)：111-118.
|
| [14] |
Stacchiotti S, Miah AB, Frezza AM, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts[J]. ESMO open, 2021, 6(3): 100170.
|
| [15] |
Shiba S, Imaoka H, Shioji K, et al. Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study[J]. BMC cancer, 2018, 18(1): 1-7.
|
| [16] |
Gaur S, Torabi A, O’Neill T J. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report[J]．Cancer Biol Med, 2012, 9(2): 133.
|
| [17] |
Stacchiotti S, Provenzano S, Dagrada G, et al. Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the Italian Rare Cancer Network database[J]．Ann Surg Oncol, 2016, 23(9): 2735-2744.
|
| [18] |
Liu X, Zhang Z, Huang J, et al. Efficacy and safety of interferon-alpha 2b for patients with hepatic epithelioid hemangioendothelioma: outcomes of a case-series analysis[J]. Cancer Manag Res, 2021, 13: 8273.
|
| [19] |
Shibayama T, Makise N, Motoi T, et al. Clinicopathologic characterization of epithelioid hemangioendothelioma in a series of 62 cases: a proposal of risk stratification and identification of a synaptophysin-positive aggressive subset[J]. Am J Surg Pathol, 2021, 45(5): 616-626.
|